(link to article in the comments) #GLP1s #WeightLossDrugs #EmployeeBenefits To view or add a comment, sign in 27% of employers say GLP-1 weight-loss drugs made up more than 15% of their total annual claims in 2024
We will look at how semaglutide works, how it affects digestion, and whether its side effects could increase the risk of developing hemorrhoids
This can include contamination, bad compounding, wrong doses, or sterilization problems in injectable drugs
3.2 Cognitive decline and Alzheimers disease Recent human and animal research has emphasized the importance of choline intake in preventing neurodegenerative diseases such as Alzheimers disease (163)
Mark Schneider, Nestle CEO Future Outlook Companies are adopting diverse strategies, from launching new product lines to utilizing existing ingredients and repositioning current products to cater to the growing GLP-1 companion food market